Timothy W. McKeithan

Author

Also Known As

T McKeithan, T W McKeithan, T W Mckeithan, T. McKeithan, T. W. McKeithan, T.W. McKeithan, TW McKeithan, Tim McKeithan, Timothy McKeithan, Timothy Mckeithan

203

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

University of Chicago University of Nebraska Medical Center City Of Hope National Medical Center National Cancer Institute BC Cancer Agency

About

Timothy W. McKeithan is an author at University of Chicago specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	38	3.7K
2	Cell Biology	20	23	2.9K
3	Natural Sciences	7	7	540
4	Biology	1	1	11
5	Biomolecular Engineering	1	1	41

Timothy W. McKeithan

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Kinetic proofreading in T-cell receptor signal transduction. Timothy W. McKeithan Proceedings of the National Academy of Sciences T-regulatory CellImmunologyImmunodominanceKinetic ProofreadingAntigen Processing	1995	964
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma Javeed Iqbal, Dennis D. Weisenburger, Timothy C. Greiner, Blood	2009	386
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells Can Küçük, Bei Jiang, Xiaozhou Hu, Nature Communications	2015	377
Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Beverly W. Baron, Giuseppina Nucifora, Norah R. McCabe, Proceedings of the National Academy of Sciences Hematological MalignancyLymphoid NeoplasiaGeneticsPathogenesisImmunology	1993	286
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma Tayla B. Heavican, Alyssa Bouska, Jiayu Yu, Blood	2019	266
IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma Chao Wang, Timothy W. McKeithan, Qiang Gong, Blood	2015	242
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Eunice N. Hatada, Alexandra Nieters, F. Gregory Wulczyn, Proceedings of the National Academy of Sciences P50 SubunitMolecular RegulationMolecular BiologyCell RegulationAnkyrin Repeat Domains	1992	234
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma Javeed Iqbal, Timothy C. Greiner, Kavita Patel, Leukemia Hematological MalignancyLymphoid NeoplasiaDifferent SubgroupsDistinctive PatternsMedicine	2007	212
Morphology in Ki-1 (CD30)-Positive Non Hodgkinʼs Lymphoma Is Correlated with Clinical Features and the Presence of a Unique Chromosomal Abnormality, t(2;5)(p23;q35) Mitchell A. Bitter, Wilbur A. Franklin, Richard A. Larson, The American Journal of Surgical Pathology	1990	197
The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation Enyu Rao, Chunsun Jiang, Ming Ji, Leukemia Cancer ResearchMantle Cell LymphomaPi3k/akt Pathway ActivationMedicineCancer Cell Biology	2011	186

Page 1